333 related articles for article (PubMed ID: 21102262)
1. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
[TBL] [Abstract][Full Text] [Related]
2. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
Hearn JW; Videtic GM; Djemil T; Stephans KL
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
[TBL] [Abstract][Full Text] [Related]
3. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
4. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.
Chen F; Matsuo Y; Yoshizawa A; Sato T; Sakai H; Bando T; Okubo K; Shibuya K; Date H
J Thorac Oncol; 2010 Dec; 5(12):1999-2002. PubMed ID: 21102261
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
7. The feasibility and efficacy of stereotactic body radiotherapy for centrally-located lung tumors.
Takahashi W; Yamashita H; Omori M; Kitaguchi M; Shibata-Kobayashi S; Sakumi A; Nakagawa K
Anticancer Res; 2013 Nov; 33(11):4959-64. PubMed ID: 24222136
[TBL] [Abstract][Full Text] [Related]
8. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer.
Matsuo Y; Shibuya K; Nagata Y; Norihisa Y; Narabayashi M; Sakanaka K; Ueki N; Mizowaki T; Hiraoka M
J Thorac Oncol; 2012 Feb; 7(2):453-6. PubMed ID: 22252562
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
[TBL] [Abstract][Full Text] [Related]
15. Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients.
Agolli L; Valeriani M; Carnevale A; Falco T; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Mar; 35(3):1783-9. PubMed ID: 25750343
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract][Full Text] [Related]
19. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.
Coon D; Gokhale AS; Burton SA; Heron DE; Ozhasoglu C; Christie N
Clin Lung Cancer; 2008 Jul; 9(4):217-21. PubMed ID: 18650169
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]